Strengthening the HLHS heart with regenerative medicine

Dec. 20, 2016


Regenerative medicine — the ability to bioengineer and make new heart muscle and apply it to patients with weak hearts — is changing the future for children with hypoplastic left heart syndrome. (HLHS). Timothy J. Nelson, M.D., Ph.D., director of the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Joseph A. Dearani, M.D., Cardiovascular Surgery Division chair, and M. Yasir Qureshi, M.B.B.S., a pediatric cardiologist, discuss regenerative medicine and its use to strengthen weak hearts.

Learn more about clinical trials for patients with hypoplastic left heart syndrome at Mayo Clinic.